Deletion of arcD in streptococcus pneumoniae D39 impairs its capsule and attenuates virulence

Infection and Immunity

Volumn 81, Issue 10, 2013, Pages 3903-3911

  Gupta, Radha ^a   Yang, Jun ^a   Dong, Yimin ^b   Swiatlo, Edwin ^c   Zhang, Jing Ren ^a,d   Metzger, Dennis W ^a   Bai, Guangchun ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b WADSWORTH CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Tsinghua University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPORTER; BACTERIAL PROTEIN; TRANSMEMBRANE PROTEIN ARCD; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; CONTROLLED STUDY; EPITHELIUM CELL; GENE DELETION; HOMOLOGOUS RECOMBINATION; IN VITRO STUDY; MACROPHAGE; MUTAGENESIS; NONHUMAN; OTITIS MEDIA; PHAGOCYTOSIS; PNEUMONIA; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

AMINO ACID TRANSPORT SYSTEMS; ANIMALS; ANTIPORTERS; BACTEREMIA; BACTERIAL CAPSULES; BACTERIAL PROTEINS; CELL LINE; CHINCHILLA; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MICE; MUTATION; OTITIS MEDIA; PNEUMONIA, BACTERIAL; STREPTOCOCCUS PNEUMONIAE; VIRULENCE;

EID: 84884393580     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00778-13     Document Type: Article

References (65)

1. Kim KS. 2010. Acute bacterial meningitis in infants and children. Lancet Infect. Dis. 10:32-42.
2. van der Poll T, Opal SM. 2008. Host-pathogen interactions in sepsis. Lancet Infect. Dis. 8:32-43.
3. Mehr S, Wood N. 2012. Streptococcus pneumoniae-a review of carriage, infection, serotype replacement and vaccination. Paediatr. Respir. Rev. 13:258-264.
4. Hyams C, Camberlein E, Cohen JM, Bax K, Brown JS. 2010. The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms. Infect. Immun. 78:704-715.
5. Hyams C, Yuste J, Bax K, Camberlein E, Weiser JN, Brown JS. 2010. Streptococcus pneumoniae resistance to complement-mediated immunity is dependent on the capsular serotype. Infect. Immun. 78:716-725.
6. Yother J. 2011. Capsules of Streptococcus pneumoniae and other bacteria: paradigms for polysaccharide biosynthesis and regulation. Annu. Rev. Microbiol. 65:563-581.
7. Briles DE, Tart RC, Swiatlo E, Dillard JP, Smith P, Benton KA, Ralph BA, Brooks-Walter A, Crain MJ, Hollingshead SK, McDaniel LS. 1998. Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA). Clin. Microbiol. Rev. 11:645-657.
8. Shapiro ED, Berg AT, Austrian R, Schroeder D, Parcells V, Margolis A, Adair RK, Clemens JD. 1991. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N. Engl. J. Med. 325:1453-1460.
9. Swiatlo E, Ware D. 2003. Novel vaccine strategies with protein antigens of Streptococcus pneumoniae. FEMS Immunol. Med. Microbiol. 38:1-7.
10. Hansen J, Black S, Shinefield H, Cherian T, Benson J, Fireman B, Lewis E, Ray P, Lee J. 2006. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs. Pediatr. Infect. Dis. J. 25:779-781.
11. Obaro SK. 2002. The new pneumococcal vaccine. Clin. Microbiol. Infect. 8:623-633.
12. Doern GV, Heilmann KP, Huynh HK, Rhomberg PR, Coffman SL, Brueggemann AB. 2001. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob. Agents Chemother. 45:1721-1729.
13. Griswold A, Chen YY, Snyder JA, Burne RA. 2004. Characterization of the arginine deiminase operon of Streptococcus rattus FA-1. Appl. Environ. Microbiol. 70:1321-1327.
14. Venugopal V, Nadkarni GB. 1977. Regulation of the arginine dihydrolase pathway in Clostridium sporogenes. J. Bacteriol. 131:693-695.
15. Ramos F, Stalon V, Pierard A, Wiame JM. 1967. The specialization of the two ornithine carbamoyltransferases of Pseudomonas. Biochim. Biophys. Acta 139:98-106.
16. Stalon V, Ramos F, Pierard A, Wiame JM. 1972. Regulation of the catabolic ornithine carbamoyltransferase of Pseudomonas fluorescens. A comparison with the anabolic transferase and with a mutationally modified catabolic transferase. Eur. J. Biochem. 29:25-35.
17. Mitruka BM, Costilow RN. 1967. Arginine and ornithine catabolism by Clostridium botulinum. J. Bacteriol. 93:295-301.
18. Schmidt GC, Logan MA, Tytell AA. 1952. The degradation of arginine by Clostridium perfringens (BP6K). J. Biol. Chem. 198:771-783.
19. Ottow JCG. 1974. Arginine dihydrolase activity in species of the genus Bacillus revealed by thin-layer chromatography. J. Gen. Microbiol. 84: 209-213.
20. Slade HD. 1953. Hydrolysis of arginine by soluble enzymes of Streptococcus faecalis. Arch. Biochem. Biophys. 42:204-211.
21. Benga L, Goethe R, Rohde M, Valentin-Weigand P. 2004. Nonencapsulated strains reveal novel insights in invasion and survival of Streptococcus suis in epithelial cells. Cell. Microbiol. 6:867-881.
22. Marquis RE, Bender GR, Murray DR, Wong A. 1987. Arginine deiminase system and bacterial adaptation to acid environments. Appl. Environ. Microbiol. 53:198-200.
23. Dong Y, Chen YY, Snyder JA, Burne RA. 2002. Isolation and molecular analysis of the gene cluster for the arginine deiminase system from Streptococcus gordonii DL1. Appl. Environ. Microbiol. 68:5549-5553.
24. Zúñiga M, Champomier-Verges M, Zagorec M, Perez-Martinez G. 1998. Structural and functional analysis of the gene cluster encoding the enzymes of the arginine deiminase pathway of Lactobacillus sake. J. Bacteriol. 180:4154-4159.
25. Verhoogt HJ, Smit H, Abee T, Gamper M, Driessen AJ, Haas D, Konings WN. 1992. arcD, the first gene of the arc operon for anaerobic arginine catabolism in Pseudomonas aeruginosa, encodes an arginineornithine exchanger. J. Bacteriol. 174:1568-1573.
26. Driessen AJ, Poolman B, Kiewiet R, Konings W. 1987. Arginine transport in Streptococcus lactis is catalyzed by a cationic exchanger. Proc. Natl. Acad. Sci. U. S. A. 84:6093-6097.
27. Poolman B. 1990. Precursor/product antiport in bacteria. Mol. Microbiol. 4:1629-1636.
28. Poolman B, Driessen AJ, Konings WN. 1987. Regulation of arginineornithine exchange and the arginine deiminase pathway in Streptococcus lactis. J. Bacteriol. 169:5597-5604.
29. Seep-Feldhaus AH, Kalinowski J, Puhler A. 1991. Molecular analysis of the Corynebacterium glutamicum gene involved in lysine uptake. Mol. Microbiol. 5:2995-3005.
30. Bourdineaud JP, Heierli D, Gamper M, Verhoogt HJ, Driessen AJ, Konings WN, Lazdunski C, Haas D. 1993. Characterization of the arcD arginine:ornithine exchanger of Pseudomonas aeruginosa. Localization in the cytoplasmic membrane and a topological model. J. Biol. Chem. 268: 5417-5424.
31. Hava DL, LeMieux J, Camilli A. 2003. From nose to lung: the regulation behind Streptococcus pneumoniae virulence factors. Mol. Microbiol. 50: 1103-1110.
32. Lau GW, Haataja S, Lonetto M, Kensit SE, Marra A, Bryant AP, McDevitt D, Morrison DA, Holden DW. 2001. A functional genomic analysis of type 3 Streptococcus pneumoniae virulence. Mol. Microbiol. 40:555-571.
33. Polissi A, Pontiggia A, Feger G, Altieri M, Mottl H, Ferrari L, Simon D. 1998. Large-scale identification of virulence genes from Streptococcus pneumoniae. Infect. Immun. 66:5620-5629.
34. Chen H, Ma Y, Yang J, O'Brien CJ, Lee SL, Mazurkiewicz JE, Haataja S, Yan JH, Gao GF, Zhang JR. 2008. Genetic requirement for pneumo-coccal ear infection. PLoS One 3:e2950. doi:10.1371/journal.pone.0002950.
35. Joloba ML, Windau A, Bajaksouzian S, Appelbaum PC, HausdorffWP, Jacobs MR. 2001. Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media. Clin. Infect. Dis. 33:1489-1494.
36. van de Rijn I, Kessler RE. 1980. Growth characteristics of group A streptococci in a new chemically defined medium. Infect. Immun. 27: 444-448.
37. Pozzi G, Masala L, Iannelli F, Manganelli R, Havarstein LS, Piccoli L, Simon D, Morrison DA. 1996. Competence for genetic transformation in encapsulated strains of Streptococcus pneumoniae: two allelic variants of the peptide pheromone. J. Bacteriol. 178:6087-6090.
38. Lu L, Ma Y, Zhang J-R. 2006. Streptococcus pneumoniae recruits complement factor H through the amino terminus of CbpA. J. Biol. Chem. 281: 15464-15474.
39. Sung CK, Li H, Claverys JP, Morrison DA. 2001. An rpsL cassette, Janus, for gene replacement through negative selection in Streptococcus pneumoniae. Appl. Environ. Microbiol. 67:5190-5196.
40. Blumenkrantz N, Asboe-Hansen G. 1973. New method for quantitative determination of uronic acids. Anal. Biochem. 54:484-489.
41. Morona JK, Morona R, Paton JC. 2006. Attachment of capsular polysaccharide to the cell wall of Streptococcus pneumoniae type 2 is required for invasive disease. Proc. Natl. Acad. Sci. U. S. A. 103:8505-8510.
42. van Dam J, Fleer A, Snippe H. 1990. Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides. Antonie Van Leeuwenhoek 58:1-47.
43. Magee AD, Yother J. 2001. Requirement for capsule in colonization by Streptococcus pneumoniae. Infect. Immun. 69:3755-3761.
44. Schrager HM, Rheinwald JG, Wessels MR. 1996. Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection. J. Clin. Invest. 98:1954-1958.
45. National Research Council. 1996. Guide for the care and use of laboratory animals. National Academies Press, Washington, DC.
46. Wu HY, Virolainen A, Mathews B, King J, Russell MW, Briles DE. 1997. Establishment of a Streptococcus pneumoniae nasopharyngeal colonization model in adult mice. Microb. Pathog. 23:127-137.
47. El Qaidi S, Yang J, Zhang JR, Metzger DW, Bai G. 2013. The vitamin B(6) biosynthesis pathway in Streptococcus pneumoniae is controlled by pyridoxal 5=-phosphate and the transcription factor PdxR and has an impact on ear infection. J. Bacteriol. 195:2187-2196.
48. Adamou JE, Wizemann TM, Barren P, Langermann S. 1998. Adherence of Streptococcus pneumoniae to human bronchial epithelial cells (BEAS- 2B). Infect. Immun. 66:820-822.
49. Hammerschmidt S, WolffS, Hocke A, Rosseau S, Muller E, Rohde M. 2005. Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells. Infect. Immun. 73:4653-4667.
50. Wimmer F, Oberwinkler T, Bisle B, Tittor J, Oesterhelt D. 2008. Identification of the arginine/ornithine antiporter ArcD from Halobacterium salinarum. FEBS Lett. 582:3771-3775.
51. Talbot UM, Paton AW, Paton JC. 1996. Uptake of Streptococcus pneumoniae by respiratory epithelial cells. Infect. Immun. 64:3772-3777.
52. Zhu Y, Weiss EC, Otto M, Fey PD, Smeltzer MS, Somerville GA. 2007. Staphylococcus aureus biofilm metabolism and the influence of arginine on polysaccharide intercellular adhesin synthesis, biofilm formation, and pathogenesis. Infect. Immun. 75:4219-4226.
53. Kloosterman TG, Kuipers OP. 2011. Regulation of arginine acquisition and virulence gene expression in the human pathogen Streptococcus pneumoniae by transcription regulators ArgR1 and AhrC. J. Biol. Chem. 286: 44594-44605.
54. Ledesma OV, De Ruiz Holgado AP, Oliver G, De Giori GS, Raibaud P, Galpin JV. 1977. A synthetic medium for comparative nutritional studies of lactobacilli. J. Appl. Bacteriol. 42:123-133.
55. Syrogiannopoulos GA, Grivea IN, Katopodis GD, Geslin P, Jacobs MR, Beratis NG. 2000. Carriage of antibiotic-resistant Streptococcus pneumoniae in Greek infants and toddlers. Eur. J. Clin. Microbiol. Infect. Dis. 19:288-293.
56. Cundell DR, Weiser JN, Shen J, Young A, Tuomanen EI. 1995. Relationship between colonial morphology and adherence of Streptococcus pneumoniae. Infect. Immun. 63:757-761.
57. Kim JO, Weiser JN. 1998. Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae. J. Infect. Dis. 177:368-377.
58. Selinger DS, Reed WP. 1979. Pneumococcal adherence to human epithelial cells. Infect. Immun. 23:545-548.
59. Bogaert D, van Belkum A, Sluijter M, Luijendijk A, de Groot R, Rumke HC, Verbrugh HA, Hermans PW. 2004. Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet 363: 1871-1872.
60. Nelson AL, Roche AM, Gould JM, Chim K, Ratner AJ, Weiser JN. 2007. Capsule enhances pneumococcal colonization by limiting mucusmediated clearance. Infect. Immun. 75:83-90.
61. Hammerschmidt S. 2009. Surface-exposed adherence molecules of Streptococcus pneumoniae. Methods Mol. Biol. 470:29-45.
62. Swiatlo E, Champlin FR, Holman SC, Wilson WW, Watt JM. 2002. Contribution of choline-binding proteins to cell surface properties of Streptococcus pneumoniae. Infect. Immun. 70:412-415.
63. Avery OT, Macleod CM, McCarty M. 1944. Studies on the chemical nature of the substance inducing transformation of pneumococcal types: induction of transformation by a desoxyribonucleic acid fraction isolated from Pneumococcus type III. J. Exp. Med. 79:137-158.
64. Tiraby JG, Fox MS. 1973. Marker discrimination in transformation and mutation of pneumococcus. Proc. Natl. Acad. Sci. U. S. A. 70:3541-3545.
65. Macrina FL, Evans RP, Tobian JA, Hartley DL, Clewell DB, Jones KR. 1983. Novel shuttle plasmid vehicles for Escherichia-Streptococcus transgeneric cloning. Gene 25:145-150.